These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23114264)

  • 21. A.S.P.E.N. parenteral nutrition trace element product shortage considerations.
    A.S.P.E.N. Clinical Practice Committee Shortage Subcommittee
    Nutr Clin Pract; 2014 Apr; 29(2):249-51. PubMed ID: 24526700
    [No Abstract]   [Full Text] [Related]  

  • 22. A.S.P.E.N. position paper: parenteral nutrition glutamine supplementation.
    Vanek VW; Matarese LE; Robinson M; Sacks GS; Young LS; Kochevar M; ;
    Nutr Clin Pract; 2011 Aug; 26(4):479-94. PubMed ID: 21697551
    [No Abstract]   [Full Text] [Related]  

  • 23. Copper and Zinc Deficiency in a Patient Receiving Long-Term Parenteral Nutrition During a Shortage of Parenteral Trace Element Products.
    Palm E; Dotson B
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):986-9. PubMed ID: 25189172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 25. Parenteral Nutrition Electrolyte and Mineral Product Shortage Considerations.
    Plogsted S; Adams SC; Allen K; Breen HB; Cober MP; Greaves J; Mogensen KM; Ralph A; Ward C; Ybarra J; Holcombe B;
    Nutr Clin Pract; 2016 Feb; 31(1):132-4. PubMed ID: 26703958
    [No Abstract]   [Full Text] [Related]  

  • 26. [Compatibility problems in intensive care medicine].
    Schröder F
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):52-8. PubMed ID: 8173313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early total parenteral nutrition in very low birthweight infants: is it safe? Is it worth it?
    Adamkin DH
    J Pediatr; 2013 Sep; 163(3):622-4. PubMed ID: 23726543
    [No Abstract]   [Full Text] [Related]  

  • 28. Y-site compatibility of medications with parenteral nutrition.
    Robinson CA; Lee JE
    J Pediatr Pharmacol Ther; 2007 Jan; 12(1):53-9. PubMed ID: 23055843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual compatibility of sargramostim with selected antineoplastic agents, anti-infectives, or other drugs during simulated Y-site injection.
    Trissel LA; Bready BB; Kwan JW; Santiago NM
    Am J Hosp Pharm; 1992 Feb; 49(2):402-6. PubMed ID: 1554007
    [No Abstract]   [Full Text] [Related]  

  • 30. Criticism of methods used in medication Y-site mixing study.
    Klang MG; Gura KM
    Am J Health Syst Pharm; 2021 Aug; 78(17):1553-1554. PubMed ID: 33764402
    [No Abstract]   [Full Text] [Related]  

  • 31. Validity of methods used in medication Y-site mixing study.
    Ross EL; Carpenter JF
    Am J Health Syst Pharm; 2021 Aug; 78(17):1554-1555. PubMed ID: 33770161
    [No Abstract]   [Full Text] [Related]  

  • 32. Physical compatibility of nine drugs in various intravenous solutions.
    Dixon FW; Weshalek J
    Am J Hosp Pharm; 1972 Oct; 29(10):822-3. PubMed ID: 5075118
    [No Abstract]   [Full Text] [Related]  

  • 33. Overview of Home Parenteral Nutrition: An Update.
    Kirby DF; Corrigan ML; Hendrickson E; Emery DM
    Nutr Clin Pract; 2017 Dec; 32(6):739-752. PubMed ID: 29035672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral nutrition as an unexpected and preventable source of mercury exposure in preterm infants.
    Jering K; Aschner M; Beller A; Hamm EL; Langdon M; Maitre NL
    J Pediatr; 2015 Jun; 166(6):1533-5. PubMed ID: 25812777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trace Elements in Parenteral Nutrition: Considerations for the Prescribing Clinician.
    Jin J; Mulesa L; Carrilero Rouillet M
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
    Garner SS; Wiest DB
    Am J Hosp Pharm; 1990 Mar; 47(3):604-6. PubMed ID: 2107740
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of organic phosphates and filters in parenteral nutrition in Spanish hospitals].
    Gomis-Muñoz P; Izquierdo-García E; Fernández-Ferreiro A
    Farm Hosp; 2011; 35(4):216-7. PubMed ID: 21489841
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.